Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Stroke|November 15, 2003
Head computed tomography findings predict short-term stroke risk after transient ischemic attackVanja C Douglas, Clarissa M Johnston, Jacob Elkins, et al.
Cureus|May 30, 2024
Observed Differences in Patient Comorbidities and Complications Undergoing Primary Total Joint Arthroplasty Between Non-orthopaedic and Orthopaedic Referral PatientsBennett W Feuchtenberger, Michael C Marinier, Kyle Geiger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 18, 2014
Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worseningGlenn A Phillips, Kathleen W Wyrwich, Shien Guo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 12, 2013
Disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT studyEva Havrdova, Gavin Giovannoni, Dusan Stefoski, et al.
Nanotechnology|April 1, 2020
Enhancing the magnetic and inductive heating properties of Fe<sub>3</sub>O<sub>4</sub> nanoparticles via morphology controlJeotikanta Mohapatra, Meiying Xing, Julian Beatty, et al.
The Iowa Orthopaedic Journal|January 5, 2023
Resident Participation During Revision Total Knee Arthroplasty Is Not Associated With Increased Risk of 30-Day Postoperative ComplicationTrevor R Gulbrandsen, Zain M Khazi, Matthew T Gulbrandsen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Identifying an important change estimate for the Multiple Sclerosis Walking Scale-12 (MSWS-12v1) for interpreting clinical trial resultsLahar Mehta, Manjit McNeill, Jeremy Hobart, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 3, 2017
Exposure-disease response analysis of natalizumab in subjects with multiple sclerosisKumar Kandadi Muralidharan, Deb Steiner, Diogo Amarante, et al.
The Journal of Arthroplasty|December 15, 2021
A Psycholgical Intervention Delivered by Automated Mobile Phone Messaging Stabilized Hip and Knee Function During the COVID-19 Pandemic: A Randomized Controlled TrialChris A Anthony, Edward Rojas, Natalie Glass, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2017
Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE studyRalph Hb Benedict, Stanley Cohan, Sharon G Lynch, et al.
Pageof 4